Author(s):
1. Arslan Naeem:
Department of Gastroenterology, Beth Israel Deaconess Medical Centre, Boston, MA,USA
2. Iqbal Ratnani:
Department of Internal Medicine, Maricopa Integrated Health System Phoenix, AZ
3. Iqbal Ratnani:
Department of Anaesthesiology & Critical Care, Houston Methodist Hospital, Houston, TX-United States
Abstract:
Liposarcoma arising in the thoracic cavity is a rare entity. It is usually found in the retroperitoneal space and the extremities. No case of thoracic liposarcoma in a patient suffering from the end-stage renal disease has been reported in the literature. We herein present the first case of thoracic liposarcoma in a patient suffering from the end-stage renal disease. Metabolic disturbances, increased use of erythropoietin and increased diagnostic workup attributes to greater risk of cancer in patients suffering from renal failure. A chemotherapeutic drug, Trabectedin has been approved for advanced liposarcoma. Prognosis of such tumours depends on the size, location, and their histological subtype.
Page(s):
286-289
DOI:
DOI not available
Published:
Journal: Journal of Ayub Medical College, Volume: 31, Issue: 2, Year: 2019
Keywords:
Thoracic cavity
,
Liposarcoma
,
Trabectedin
,
Erythropoietin
References:
References are not available for this document.
Citations
Citations are not available for this document.